Loyola University Chicago Exclusive License Agreement Bio-Bridge Science Corporation Page 1 of 5 ------------------------------------------------------- ------------------------- EXCLUSIVE LICENSE AGREEMENT WHEREAS Liang Qiao and Wei Shi, of 6526...Exclusive License Agreement • December 30th, 2004 • Bio Bridge Science Inc • Illinois
Exclusive Agency Agreement This agreement is made and entered into by and between the parties concerned in Beijing, China on the basis of equality and mutual benefit to develop business on terms and conditions mutually agreed upon as follow: The...Exclusive Agency Agreement • November 21st, 2005 • Bio Bridge Science Inc • Pharmaceutical preparations
NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE...Security Agreement • April 15th, 2011 • Bio Bridge Science Inc • Pharmaceutical preparations
THIS CLASS CB COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ______________(the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the fifth anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BIO-BRIDGE SCIENCE, Inc., a Delaware corporation (the “Company”), up to _________ shares (the “Warrant Shares”) of Common Stock, par value $0.001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Exhibit 2.1 AGREEMENT FOR THE EXCHANGE OF SHARES This Agreement is made among the following parties and is dated the 4th day of November 2004: 1. Bio-Bridge Science Corp., having its registered office at Offshore Incorporations (Cayman) Limited...Agreement for the Exchange of Shares • December 30th, 2004 • Bio Bridge Science Inc
Exhibit 4.1 Lease Agreement (Translated from the original Chinese agreement)Lease Agreement • August 10th, 2006 • Bio Bridge Science Inc • Pharmaceutical preparations
Lease Agreement (Translated from the original Chinese agreement)Lease Agreement • August 10th, 2007 • Bio Bridge Science Inc • Pharmaceutical preparations
Party A is the owner of Suite 1812, No.199, Moma Building, Chaoyang North Road, Chaoyang District, Beijing, China Party B desires to rent and Party A agrees to rent the above-mentioned premise.
CLASS BA COMMON STOCK PURCHASE WARRANT To Purchase __________ Shares of Common Stock of BIO-BRIDGE SCIENCE, INC.Securities Agreement • July 3rd, 2008 • Bio Bridge Science Inc • Pharmaceutical preparations
THIS CLASS BA COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the fourth anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from BIO-BRIDGE SCIENCE, Inc., a Delaware corporation (the “Company”), up to __________shares (the “Warrant Shares”) of Common Stock, par value $0.001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
ContractRegulation S Securities Purchase Agreement • July 11th, 2008 • Bio Bridge Science Inc • Pharmaceutical preparations • Illinois
Regulation S Securities Purchase Agreement(“ Purchase Agreement”), effective as of July 9, 2008 between Bio-Bridge Science, Inc., a Delaware corporation (“Seller”), the address of which is located on the signature page hereto, and Cheung Hin Shun Anthony (a “Purchaser”), the address of which is located on the signature page hereto. The Seller and the Purchaser, intending to be bound and for good and valuable consideration, the receipt and sufficiency of which is acknowledged, agree as follows:
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 2nd, 2007 • Bio Bridge Science Inc • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of January__________, 2007, among Bio-Bridge Science, Inc., a Delaware corporation (the “Company”), and the purchasers signatory hereto (each such purchaser is a “Purchaser” and all such purchasers are, collectively, the “Purchasers”).
ContractSecurities Purchase Agreement • April 15th, 2011 • Bio Bridge Science Inc • Pharmaceutical preparations • Illinois
Regulation S Securities Purchase Agreement (“ Purchase Agreement”), effective as of December ___, 2010, between Bio-Bridge Science, Inc., a Delaware corporation (“Seller”), the address of which is located on the signature page hereto, and Anthony Hin Shun Cheung (a “Purchaser”), the address of which is located on the signature page hereto. The Seller and the Purchaser, intending to be bound and for good and valuable consideration, the receipt and sufficiency of which is acknowledged, agree as follows:
AGREEMENT ON BIODISTRIBUTION AND INTEGRATION STUDIES OF HIV-PV VACCINE IN MICE Instructions The Agreement is a legal-binding document that the Bio-Bridge (Beijing) Science Corporation (Party A) and the Beijing Institute of Radiation Medicine (Party B)...Agreement on Biodistribution and Integration Studies of Hiv-Pv Vaccine in Mice • May 2nd, 2005 • Bio Bridge Science Inc • Pharmaceutical preparations
Purui Xinheng Baide Shengwu Keji (Nei Menggu) Youxian Gongsi Equity Interest Transfer Contract BetweenEquity Interest Transfer Contract • December 15th, 2010 • Bio Bridge Science Inc • Pharmaceutical preparations
This equity interest transfer contract (hereinafter referred to as the “Contract”) is entered into on December 11, 2010, by and among
AMENDMENT NO. 2 TO EXCLUSIVE AGENCY AGREEMENT DATED DECEMBER 9, 2009Exclusive Agency Agreement • November 12th, 2010 • Bio Bridge Science Inc • Pharmaceutical preparations
Xinhua Surgical Instruments Co., Ltd. (“Party A” or “Xinhua”) and Bio-Bridge Science, Inc. (“Bio-Bridge” or “ Party B”) hereby at December 9, 2009 enter into the following amendment to the Exclusive Agency Agreement (“the Agreement”) dated March 17, 2008 to replace Section 4 of the Agreement.
FIRST AMENDMENT TO LEASELease • August 10th, 2007 • Bio Bridge Science Inc • Pharmaceutical preparations
This FIRST AMENDMENT TO LEASE (this "Amendment") is entered into as of the 1st day of June, 2007 by and between SFERS REAL ESTATE K LIMITED PARTNERSHIP, an Ohio limited partnership, by RREEF MANAGEMENT COMPANY, a Delaware corporation ("Landlord"), and BIO-BRIDGE SCIENCE INC., a Delaware corporation ("Tenant"), for certain premises located in the building commonly known as 1211 West 22nd Street, Oak Brook, Illinois (the "Building").
Sale and Purchase Agreement THIS AGREEMENT is made on APRIL 30, 2008 in the city of Beijing, China BETWEEN:Sale and Purchase Agreement • May 1st, 2008 • Bio Bridge Science Inc • Pharmaceutical preparations • Macau
In this Agreement and its appendices, unless the context otherwise requires, the following expressions have the following meanings:
AMENDMENT NO. 1 TO EXCLUSIVE AGENCY AGREEMENT DATED MARCH 17, 2008Exclusive Agency Agreement • November 12th, 2010 • Bio Bridge Science Inc • Pharmaceutical preparations
Xinhua Surgical Instruments Co., Ltd. (“Party A” or “Xinhua”) and Bio-Bridge Science, Inc. (“Bio-Bridge” or “ Party B”) hereby at March 10, 2009 enter into the following amendment to the Exclusive Agency Agreement (“the Agreement”) dated March 17, 2008 to replace Section 5 of the Agreement.
Exclusive Agency AgreementExclusive Agency Agreement • March 31st, 2008 • Bio Bridge Science Inc • Pharmaceutical preparations
This agreement is made and entered into by and between the parties concerned on March 17th, 2008 in Beijing, China on the basis of equality and mutual benefit to develop business on terms and conditions mutually agreed upon as follow and supersedes the prior signed agreement in 2005:
LAND USE RIGHT AGREEMENT ( THIS IS ONLY A TRANSLATION OF THE ORIGINAL CHINESE VERSION OF AGREEMENT) Party A: Beijing Airport High-Tech Park Co. Ltd Party B: Bio-Bridge Science (Beijing) Co. Ltd Beijing Airport High-Tech Park Co. Ltd is a legal...Land Use Right Agreement • May 2nd, 2005 • Bio Bridge Science Inc • Pharmaceutical preparations
Beijing Bio-Bridge Science Corporation Exclusive Sub-License Agreement Bio- Bridge Science Corporation Page 1 of 3 ---------------------------------------- ---------------------------------------- EXCLUSIVE SUB-LICENSE AGREEMENT WHEREAS Liang Qiao and...Exclusive Sub-License Agreement • December 30th, 2004 • Bio Bridge Science Inc
AGREEEMENT ON PRE-CLINICAL SAFETY ASSESSMENT OF THERAPEUTICAL HIV-PV PSEUDOVIRUS VACCINE Instructions The Agreement is a legal-binding document that the Bio-Bridge (Beijing) Science Corporation (Party A) and the Beijing Institute of Radiation Medicine...Pre-Clinical Safety Assessment Agreement • May 2nd, 2005 • Bio Bridge Science Inc • Pharmaceutical preparations
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 2nd, 2007 • Bio Bridge Science Inc • Pharmaceutical preparations • Illinois
This Securities Purchase Agreement (this “Agreement”) is dated as of January ______, 2007, by and among BIO-BRIDGE SCIENCE, INC., a Delaware corporation (the “Company”), and the purchasers listed in the exhibit and identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Bio-bridge Science (HK) Co., Ltd J R Scientific, Inc. Beijing Boda Times Science and Trade Co., Ltd Beijing Zhongpu Huaxing Biotechnology Co., Ltd Huhhot Haibo Biologic Production Co., LtdEquity Joint Venture Contract • June 10th, 2009 • Bio Bridge Science Inc • Pharmaceutical preparations
Party A, Party B, Party C, Party D, Party E and Party F will hereinafter be referred to collectively as the “Parties” and individually as a “Party”.
